These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36952476)

  • 1. Histone demethylase KDM4B contributes to advanced clear cell renal carcinoma and association with copy number variations and cell cycle progression.
    Tang H; Guan Y; Yuan Z; Guo T; Tan X; Fan Y; Zhang E; Wang X
    Epigenetics; 2023 Dec; 18(1):2192319. PubMed ID: 36952476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone demethylase KDM4B accelerates the progression of glioblastoma via the epigenetic regulation of MYC stability.
    Wang Z; Cai H; Li Z; Sun W; Zhao E; Cui H
    Clin Epigenetics; 2023 Dec; 15(1):192. PubMed ID: 38093312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone Demethylase KDM4B Promotes DNA Damage by Activating Long Interspersed Nuclear Element-1.
    Xiang Y; Yan K; Zheng Q; Ke H; Cheng J; Xiong W; Shi X; Wei L; Zhao M; Yang F; Wang P; Lu X; Fu L; Lu X; Li F
    Cancer Res; 2019 Jan; 79(1):86-98. PubMed ID: 30459150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KDM4B, a potential prognostic biomarker revealed by large-scale public databases and clinical samples in uterine corpus endometrial carcinoma.
    Zhang M; Liu Y; Hou S; Wang Y; Wang C; Yin Y; Chen X
    Mol Omics; 2022 Jul; 18(6):506-519. PubMed ID: 35485290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of histone demethylase KDM4B in Myc signaling in neuroblastoma.
    Yang J; AlTahan AM; Hu D; Wang Y; Cheng PH; Morton CL; Qu C; Nathwani AC; Shohet JM; Fotsis T; Koster J; Versteeg R; Okada H; Harris AL; Davidoff AM
    J Natl Cancer Inst; 2015 Jun; 107(6):djv080. PubMed ID: 25925418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic targeting of histone lysine demethylase KDM4B blocks the growth of castration-resistant prostate cancer.
    Duan L; Chen YA; Liang Y; Chen Z; Lu J; Fang Y; Cao J; Lu J; Zhao H; Pong RC; Hernandez E; Kapur P; Tran TAT; Smith T; Martinez ED; Ahn JM; Hsieh JT; Luo JH; Liu ZP
    Biomed Pharmacother; 2023 Feb; 158():114077. PubMed ID: 36495660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the KDM4B-AR-c-Myc axis promotes sensitivity to androgen receptor-targeted therapy in advanced prostate cancer.
    Tang DE; Dai Y; He JX; Lin LW; Leng QX; Geng XY; Fu DX; Jiang HW; Xu SH
    J Pathol; 2020 Oct; 252(2):101-113. PubMed ID: 32617978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA HOTAIR promotes metastasis of renal cell carcinoma by up-regulating histone H3K27 demethylase JMJD3.
    Xia M; Yao L; Zhang Q; Wang F; Mei H; Guo X; Huang W
    Oncotarget; 2017 Mar; 8(12):19795-19802. PubMed ID: 28177890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1.
    Qiu MT; Fan Q; Zhu Z; Kwan SY; Chen L; Chen JH; Ying ZL; Zhou Y; Gu W; Wang LH; Cheng WW; Zeng J; Wan XP; Mok SC; Wong KK; Bao W
    Oncotarget; 2015 Oct; 6(31):31702-20. PubMed ID: 26397136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer.
    Wilson C; Qiu L; Hong Y; Karnik T; Tadros G; Mau B; Ma T; Mu Y; New J; Louie RJ; Gunewardena S; Godwin AK; Tawfik OW; Chien J; Roby KF; Krieg AJ
    Oncogene; 2017 May; 36(18):2565-2576. PubMed ID: 27869162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KDM4B facilitates colorectal cancer growth and glucose metabolism by stimulating TRAF6-mediated AKT activation.
    Li H; Lan J; Wang G; Guo K; Han C; Li X; Hu J; Cao Z; Luo X
    J Exp Clin Cancer Res; 2020 Jan; 39(1):12. PubMed ID: 31931846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression pattern and regulatory effect of lysine-specific demethylase 2A gene in clear cell renal cell carcinoma.
    Wang J; Li T; Li X; Zhang Y; Wang X
    BMC Urol; 2021 Aug; 21(1):108. PubMed ID: 34391411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KDM4B down-regulation facilitated breast cancer cell stemness via PHGDH upregulation in H3K36me3-dependent manner.
    Wang XY; Li HM; Xia R; Li X; Zhang X; Jin TZ; Zhang HS
    Mol Cell Biochem; 2024 Apr; 479(4):915-928. PubMed ID: 37249813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different expression patterns of histone H3K27 demethylases in renal cell carcinoma and bladder cancer.
    Hong Z; Li H; Li L; Wang W; Xu T
    Cancer Biomark; 2017; 18(2):125-131. PubMed ID: 27983522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KDM4B promotes epithelial-mesenchymal transition through up-regulation of ZEB1 in pancreatic cancer.
    Li S; Wu L; Wang Q; Li Y; Wang X
    Acta Biochim Biophys Sin (Shanghai); 2015 Dec; 47(12):997-1004. PubMed ID: 26511091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and significance of histone H3K27 demethylases in renal cell carcinoma.
    Shen Y; Guo X; Wang Y; Qiu W; Chang Y; Zhang A; Duan X
    BMC Cancer; 2012 Oct; 12():470. PubMed ID: 23057811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone lysine demethylase 4B regulates general and unique gene expression signatures in hypoxic cancer cells.
    Qiu L; Meng Y; Wang L; Gunewardena S; Liu S; Han J; Krieg AJ
    MedComm (2020); 2021 Sep; 2(3):414-429. PubMed ID: 34766154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock protein 90 (Hsp90) selectively regulates the stability of KDM4B/JMJD2B histone demethylase.
    Ipenberg I; Guttmann-Raviv N; Khoury HP; Kupershmit I; Ayoub N
    J Biol Chem; 2013 May; 288(21):14681-7. PubMed ID: 23589305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the histone demethylase KDM4B leads to activation of KDM1A, attenuates bacterial-induced pro-inflammatory cytokine release, and reduces osteoclastogenesis.
    Kirkpatrick JE; Kirkwood KL; Woster PM
    Epigenetics; 2018; 13(5):557-572. PubMed ID: 29927684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4B-mediated demethylation.
    Zhang H; Zhang K; Xu Z; Chen Z; Wang Q; Wang C; Cui J
    BMC Cancer; 2021 Feb; 21(1):163. PubMed ID: 33588776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.